Posttransplant lymphoproliferative disorder in adults receiving kidney transplantation in British Columbia: a retrospective cohort analysis
… Among the patients who received rituximab, 16 achieved remission without recurrence (Table 3). Among all PTLD patients, the 1- and 2-year patient survival rates were 78.4% and 75.7…..... Read More